{"id":3092,"date":"2026-04-10T08:29:03","date_gmt":"2026-04-10T05:29:03","guid":{"rendered":"https:\/\/merkezlaboratuvari.com\/test-listesi\/ca-15-3-2\/"},"modified":"2026-04-21T12:38:54","modified_gmt":"2026-04-21T09:38:54","slug":"ca-15-3","status":"publish","type":"page","link":"https:\/\/merkezlaboratuvari.com\/ar\/test-listesi\/ca-15-3\/","title":{"rendered":"CA 15-3"},"content":{"rendered":"<h1>CA 15-3<\/h1>\n<h2>Laboratuvar Bilgileri<\/h2>\n<ul>\n<li><strong>Yeni Kod:<\/strong> BIO9173<\/li>\n<li><strong>SUT Kodu:<\/strong> L101920<\/li>\n<li><strong>Eski Kod:<\/strong> HR0019<\/li>\n<li><strong>Kategori:<\/strong> \u0643\u064a\u0645\u064a\u0627\u0621 \u062d\u064a\u0648\u064a\u0629<\/li>\n<li><strong>Numune T\u00fcr\u00fc:<\/strong> Serum<\/li>\n<li><strong>Numune Kab\u0131:<\/strong> Sar\u0131 Kapak<\/li>\n<li><strong>\u00c7al\u0131\u015fma G\u00fcn\u00fc:<\/strong> Her g\u00fcn<\/li>\n<li><strong>\u00d6nemli Kriter:<\/strong> \u00c7al\u0131\u015fma g\u00fcn\u00fcnde laboratuvar\u0131m\u0131zda kabul edilen testler, bir sonraki \u00e7al\u0131\u015fma program\u0131nda i\u015fleme al\u0131nacakt\u0131r.<\/li>\n<li><strong>Raporlama Tarihi:<\/strong> Ertesi g\u00fcn 18:00<\/li>\n<\/ul>\n<h2>CA 15-3 Testi Nedir?<\/h2>\n<p>CA 15-3, laboratuvar ortam\u0131nda de\u011ferlendirilen bir biyokimya testidir. De\u011ferlendirme \u00e7o\u011fu zaman serum \u00f6rne\u011fi \u00fczerinden planlan\u0131r.<\/p>\n<p>CA 15-3 (Cancer Antigen 15-3), MUC1 geni taraf\u0131ndan kodlanan bir transmembran glikoproteindir. Ba\u015fl\u0131ca meme kanseri ile ili\u015fkili bir t\u00fcm\u00f6r belirtecidir. Meme kanserinin taranmas\u0131nda de\u011fil, tan\u0131 konmu\u015f meme kanserinin tedavi yan\u0131t\u0131 izlenmesi, metastatik hastal\u0131\u011f\u0131n takibi ve n\u00fcks de\u011ferlendirmesinde kullan\u0131l\u0131r.<\/p>\n<p>Bu testin klinik anlam\u0131; istem nedeni, hastan\u0131n yak\u0131nmalar\u0131, ya\u015f\u0131, e\u015flik eden hastal\u0131klar\u0131, kullan\u0131lan y\u00f6ntem ve di\u011fer laboratuvar bulgular\u0131 ile birlikte de\u011ferlendirilir. Bu nedenle sonu\u00e7, tek ba\u015f\u0131na de\u011fil, b\u00fct\u00fcnc\u00fcl t\u0131bbi \u00e7er\u00e7eve i\u00e7inde yorumlanmal\u0131d\u0131r.<\/p>\n<h2>CA 15-3 Hangi Durumlarda \u0130stenir?<\/h2>\n<p>CA 15-3 testi, hekim taraf\u0131ndan klinik gereklilik g\u00f6r\u00fclen durumlarda istenebilir. \u0130stem gerek\u00e7esi hastan\u0131n mevcut tablosuna g\u00f6re de\u011fi\u015febilir.<\/p>\n<ul>\n<li>Metastatik meme kanseri tedavi yan\u0131t\u0131n\u0131n izlenmesi<\/li>\n<li>Meme kanseri n\u00fcks takibi<\/li>\n<li>Metastatik hastal\u0131\u011f\u0131n yayg\u0131nl\u0131\u011f\u0131n\u0131n de\u011ferlendirilmesi<\/li>\n<li>Kemoterapi ve hormonoterapi etkinli\u011finin izlenmesi<\/li>\n<li>CEA ile birlikte meme kanseri takibinde<\/li>\n<\/ul>\n<p>Ayn\u0131 test farkl\u0131 hastalarda farkl\u0131 klinik sorulara yan\u0131t aramak amac\u0131yla kullan\u0131labildi\u011fi i\u00e7in, nihai de\u011ferlendirme her zaman ki\u015fisel t\u0131bbi \u00f6yk\u00fc ve muayene bulgular\u0131 ile birlikte yap\u0131lmal\u0131d\u0131r.<\/p>\n<h2>CA 15-3 Testi \u00d6ncesi Haz\u0131rl\u0131k<\/h2>\n<p>Haz\u0131rl\u0131k gereksinimi; testin t\u00fcr\u00fcne, numune yap\u0131s\u0131na ve laboratuvar\u0131n \u00e7al\u0131\u015fma kurallar\u0131na g\u00f6re de\u011fi\u015febilir. Test \u00f6ncesinde laboratuvar\u0131n ve hekimin verdi\u011fi talimatlar esas al\u0131nmal\u0131d\u0131r.<\/p>\n<ul>\n<li>\u00d6zel bir haz\u0131rl\u0131k gerekmez.<\/li>\n<li>A\u00e7l\u0131k \u015fart\u0131 yoktur.<\/li>\n<li>Kullan\u0131lan ila\u00e7lar ve mevcut hastal\u0131klar hakk\u0131nda hekime bilgi verilmelidir.<\/li>\n<\/ul>\n<p>Kullan\u0131lan ila\u00e7lar, takviyeler, yak\u0131n d\u00f6nemde ge\u00e7irilen hastal\u0131klar ve e\u015flik eden kronik durumlar sonucun yorumlanmas\u0131n\u0131 etkileyebilece\u011fi i\u00e7in sa\u011fl\u0131k profesyoneli ile payla\u015f\u0131lmal\u0131d\u0131r.<\/p>\n<h2>CA 15-3 Testi Nas\u0131l Yap\u0131l\u0131r?<\/h2>\n<p>CA 15-3 testi, uygun biyolojik \u00f6rnek al\u0131nd\u0131ktan sonra laboratuvar\u0131n belirledi\u011fi y\u00f6ntemle \u00e7al\u0131\u015f\u0131l\u0131r. Numunenin do\u011fru zamanda, uygun kapta ve uygun ta\u015f\u0131ma ko\u015fullar\u0131nda ula\u015ft\u0131r\u0131lmas\u0131 test kalitesi a\u00e7\u0131s\u0131ndan \u00f6nem ta\u015f\u0131r.<\/p>\n<ul>\n<li><strong>Numune T\u00fcr\u00fc:<\/strong> Serum<\/li>\n<li><strong>Numune Kab\u0131:<\/strong> Sar\u0131 Kapak<\/li>\n<li><strong>\u00c7al\u0131\u015fma G\u00fcn\u00fc:<\/strong> Her g\u00fcn<\/li>\n<li><strong>\u00d6nemli Kriter:<\/strong> \u00c7al\u0131\u015fma g\u00fcn\u00fcnde laboratuvar\u0131m\u0131zda kabul edilen testler, bir sonraki \u00e7al\u0131\u015fma program\u0131nda i\u015fleme al\u0131nacakt\u0131r.<\/li>\n<li><strong>Raporlama Tarihi:<\/strong> Ertesi g\u00fcn 18:00<\/li>\n<\/ul>\n<ul>\n<li>Koldan ven\u00f6z kan \u00f6rne\u011fi al\u0131n\u0131r (serum t\u00fcp\u00fcne).<\/li>\n<li>\u0130\u015flem birka\u00e7 dakika s\u00fcrer.<\/li>\n<li>Sonu\u00e7lar genellikle ayn\u0131 g\u00fcn veya ertesi g\u00fcn \u00e7\u0131kar.<\/li>\n<\/ul>\n<p>Baz\u0131 durumlarda \u00f6rnek kalitesi, numune miktar\u0131, ta\u015f\u0131ma s\u00fcresi veya teknik tekrar gereksinimi raporlama s\u00fcresini ve sonucun g\u00fcvenilirli\u011fini etkileyebilir.<\/p>\n<h2>CA 15-3 Testi Ka\u00e7 G\u00fcnde \u00c7\u0131kar?<\/h2>\n<p>Mevcut laboratuvar bilgisine g\u00f6re bu test i\u00e7in raporlama s\u00fcresi: <strong>Ertesi g\u00fcn 18:00<\/strong> \u015feklindedir.<\/p>\n<p>Numunenin kabul zaman\u0131, laboratuvar\u0131n \u00e7al\u0131\u015fma plan\u0131, resmi tatiller veya gerekti\u011finde tekrar \u00e7al\u0131\u015fma gibi etkenler sonucu etkileyebilece\u011fi i\u00e7in en g\u00fcncel bilgi rapor tarihi \u00fczerinden de\u011ferlendirilmelidir.<\/p>\n<h2>Referans De\u011ferleri ve Sonu\u00e7lar\u0131n De\u011ferlendirilmesi<\/h2>\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Grup<\/th><th>De\u011fer<\/th><\/tr><\/thead><tbody><tr><td>Yeti\u015fkinler<\/td><td>0 \u2013 31.3 U\/mL<\/td><\/tr><\/tbody><\/table><\/figure>\n\n<p>> Not: Referans de\u011ferleri laboratuvara ve kullan\u0131lan y\u00f6nteme g\u00f6re farkl\u0131l\u0131k g\u00f6sterebilir.<\/p>\n<p>Referans bilgileri; kullan\u0131lan y\u00f6ntem, ya\u015f grubu, biyolojik \u00f6rnek tipi ve laboratuvar standard\u0131na g\u00f6re de\u011fi\u015febilece\u011finden, rapor \u00fczerinde yer alan laboratuvar yorumu esas al\u0131nmal\u0131d\u0131r.<\/p>\n<h2>CA 15-3 Sonucu Nas\u0131l Yorumlan\u0131r?<\/h2>\n<p>Test sonucu tek ba\u015f\u0131na kesin tan\u0131 koydurmaz. Sonu\u00e7; klinik bulgular, di\u011fer laboratuvar verileri ve gerekli g\u00f6r\u00fcld\u00fc\u011f\u00fcnde ek incelemeler ile birlikte de\u011ferlendirilir.<\/p>\n<h3>Y\u00fcksek CA 15-3 D\u00fczeyleri<\/h3>\n<p><strong>Malign nedenler:<\/strong><\/p>\n<ul>\n<li>Meme kanseri (\u00f6zellikle metastatik)<\/li>\n<li>Over kanseri<\/li>\n<li>Akci\u011fer kanseri<\/li>\n<li>Pankreas kanseri<\/li>\n<li>Kolorektal kanser<\/li>\n<li>Karaci\u011fer kanseri<\/li>\n<\/ul>\n<p><strong>Benign nedenler:<\/strong><\/p>\n<ul>\n<li>Meme fibroadenomu<\/li>\n<li>Benign meme hastal\u0131klar\u0131<\/li>\n<li>Karaci\u011fer sirozu, hepatit<\/li>\n<li>Lupus (SLE)<\/li>\n<li>Sarkoidoz<\/li>\n<li>T\u00fcberk\u00fcloz<\/li>\n<li>B\u00f6brek yetmezli\u011fi<\/li>\n<\/ul>\n<h3>Takipte CA 15-3 De\u011fi\u015fimleri<\/h3>\n<ul>\n<li><strong>Tedavi ile d\u00fc\u015f\u00fc\u015f:<\/strong> Kemoterapiye veya hormonoterapiye olumlu yan\u0131t\u0131 g\u00f6sterir.<\/li>\n<li><strong>Ge\u00e7ici y\u00fckselme (spike):<\/strong> Kemoterapi ba\u015flang\u0131c\u0131nda ge\u00e7ici bir y\u00fckselme g\u00f6r\u00fclebilir; bu her zaman hastal\u0131k ilerlemesi anlam\u0131na gelmez.<\/li>\n<li><strong>S\u00fcrekli y\u00fckselme:<\/strong> Hastal\u0131k progresyonu veya metastaz d\u00fc\u015f\u00fcnd\u00fcr\u00fcr.<\/li>\n<li><strong>Yeniden y\u00fckselme:<\/strong> Tedavi sonras\u0131 remisyonda iken y\u00fckselme n\u00fcks a\u00e7\u0131s\u0131ndan uyar\u0131c\u0131d\u0131r.<\/li>\n<\/ul>\n<h3>\u00d6nemli Notlar<\/h3>\n<ul>\n<li>CA 15-3 tarama testi olarak kullan\u0131lmaz; erken evre meme kanserinde genellikle y\u00fckselmez.<\/li>\n<li>Metastatik meme kanserinde duyarl\u0131l\u0131\u011f\u0131 %60-80 aras\u0131ndad\u0131r.<\/li>\n<li>Tek bir y\u00fcksek de\u011fer yerine seri \u00f6l\u00e7\u00fcmlerle takip daha anlaml\u0131d\u0131r.<\/li>\n<li>CEA ile birlikte de\u011ferlendirildi\u011finde tan\u0131sal de\u011feri artar.<\/li>\n<li>\u0130lk kemoterapi k\u00fcrlerinde ge\u00e7ici y\u00fckselme (flare) olabilece\u011fi ak\u0131lda tutulmal\u0131d\u0131r.<\/li>\n<\/ul>\n<p>\u00d6zellikle s\u0131n\u0131rda, d\u00fc\u015f\u00fck d\u00fczeyli veya beklenmeyen sonu\u00e7larda klinik korelasyon gerekir. Gerekti\u011finde tekrar test, panel de\u011ferlendirmesi veya ek laboratuvar incelemeleri planlanabilir.<\/p>\n<h2>Testin S\u0131n\u0131rl\u0131l\u0131klar\u0131<\/h2>\n<p>Her laboratuvar testinde oldu\u011fu gibi bu incelemenin de baz\u0131 s\u0131n\u0131rl\u0131l\u0131klar\u0131 vard\u0131r. Sonu\u00e7; \u00f6rnek kalitesi, \u00f6rnekleme zaman\u0131, ta\u015f\u0131ma ko\u015fullar\u0131 ve klinik ba\u011flamdan etkilenebilir.<\/p>\n<ul>\n<li>Tek bir laboratuvar sonucu, klinik \u00e7er\u00e7eve d\u0131\u015f\u0131nda eksik yorumlanabilir.<\/li>\n<li>Uygun olmayan numune kalitesi sonucun g\u00fcvenilirli\u011fini azaltabilir.<\/li>\n<li>Gerekti\u011finde ek testler olmadan tek ba\u015f\u0131na karar vermek yan\u0131lt\u0131c\u0131 olabilir.<\/li>\n<\/ul>\n<h2>Olas\u0131 Riskler<\/h2>\n<p>Risk \u00e7o\u011funlukla numune alma ve numune y\u00f6netimi s\u00fcreci ile ili\u015fkilidir. Testin kendisinden \u00e7ok, \u00f6rne\u011fin al\u0131nmas\u0131 ve uygun ko\u015fullarda \u00e7al\u0131\u015f\u0131lmas\u0131 \u00f6nem ta\u015f\u0131r.<\/p>\n<ul>\n<li>Kan al\u0131m\u0131na ba\u011fl\u0131 hafif a\u011fr\u0131, morarma veya \u015fi\u015flik olabilir.<\/li>\n<li>Nadiren enfeksiyon veya a\u015f\u0131r\u0131 kanama g\u00f6r\u00fclebilir.<\/li>\n<li>Testin kendisine ba\u011fl\u0131 ciddi bir risk yoktur.<\/li>\n<li><strong>Yanl\u0131\u015f pozitif:<\/strong> Benign meme hastal\u0131klar\u0131 ve karaci\u011fer hastal\u0131klar\u0131nda y\u00fckselebilir.<\/li>\n<li><strong>Yanl\u0131\u015f negatif:<\/strong> Erken evre meme kanserinde ve baz\u0131 alt tiplerde normal kalabilir.<\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>CA 15-3 Laboratuvar Bilgileri Yeni Kod: BIO9173 SUT Kodu: L101920 Eski Kod: HR0019 Kategori: Biyokimya Numune T\u00fcr\u00fc: Serum Numune Kab\u0131: Sar\u0131 Kapak \u00c7al\u0131\u015fma G\u00fcn\u00fc: Her g\u00fcn \u00d6nemli Kriter: \u00c7al\u0131\u015fma g\u00fcn\u00fcnde laboratuvar\u0131m\u0131zda kabul edilen testler, bir sonraki \u00e7al\u0131\u015fma program\u0131nda i\u015fleme al\u0131nacakt\u0131r. Raporlama Tarihi: Ertesi g\u00fcn 18:00 CA 15-3 Testi Nedir? CA 15-3, laboratuvar ortam\u0131nda de\u011ferlendirilen bir [&hellip;]<\/p>\n","protected":false},"author":0,"featured_media":0,"parent":5,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"test_category":"Biyokimya","test_kodu":"BIO9173","numune_turu":"Serum","numune_kabi":"Sar\u0131 Kapak","calisma_gunu":"Her g\u00fcn","onemli_kriter":"\u00c7al\u0131\u015fma g\u00fcn\u00fcnde laboratuvar\u0131m\u0131zda kabul edilen testler, bir sonraki \u00e7al\u0131\u015fma program\u0131nda i\u015fleme al\u0131nacakt\u0131r.","raporlama_tarihi":"Ertesi g\u00fcn 18:00","numune_red_kriterleri":"","aktarim_kodu":"","loinc_kodu":"","sut_kodu":"L101920","akredite":"","numune_miktari":"","alternatif_ornek":"","numune_alinma_sekli":"","stabilite_ozellikleri":"","calisma_yontemi":"","test_bilgisi":"","footnotes":""},"class_list":["post-3092","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages\/3092","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/types\/page"}],"replies":[{"embeddable":true,"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/comments?post=3092"}],"version-history":[{"count":5,"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages\/3092\/revisions"}],"predecessor-version":[{"id":9063,"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages\/3092\/revisions\/9063"}],"up":[{"embeddable":true,"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages\/5"}],"wp:attachment":[{"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/media?parent=3092"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}